MicroRNA expression profiling of specific cells in complex archival tissue stained by immunohistochemistry

Global implementation of molecular diagnostics in modern pathology has been limited by the use of formalin-fixed, paraffin-embedded (FFPE) tissues in current routine diagnostic procedures because of modification and degradation of nucleic acids and protein molecules. In particular, molecular analysis of a specific cell type potentially important for biomarker identification is largely prevented in highly complex, solid tissues routinely used in histopathology. Accumulating data report on the substantial contribution of microRNA molecules (miRNA) to tumor development and malignant progression of most human malignancies. Our objective was to establish a sensitive and robust procedure to quantify miRNA expression in specific cells from complex archival tumor tissues identified by immunohistochemistry. Here, we show reliable detection of miRNA expression profiles determined from limited amounts of colorectal cancer FFPE tissues after routine staining procedure. The combination of routinely used FFPE specimens stained by immunohistochemistry with the molecular analysis of lasermicrodissected complex tumor tissue resulted in robust miRNA expression patterns exclusively obtained from epithelial tumor cells. This approach allows for a detailed molecular analysis of cancer cells and distinct stromal cell types and their in situ interaction in solid tumors. Hence, the methodology can offer new perspectives for basic research and, by comprehensive use of present archival tissue collections linked to clinical databases, facilitate miRNA biomarker identification in defined tissue cells for future diagnostic and therapeutic strategies.

[1]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[2]  S. Hammond,et al.  MicroRNAs as oncogenes. , 2006, Current opinion in genetics & development.

[3]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[4]  C. Croce,et al.  miRNAs, Cancer, and Stem Cell Division , 2005, Cell.

[5]  George A Calin,et al.  MicroRNAs and cancer--new paradigms in molecular oncology. , 2009, Current opinion in cell biology.

[6]  J. Jameson,et al.  MicroRNAs are novel biomarkers of colorectal cancer , 2009, The British journal of surgery.

[7]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[8]  J. Neher A problem of multiple comparisons , 2011 .

[9]  Y. Yatabe,et al.  Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.

[10]  M. Odenthal,et al.  Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR , 2008, Journal of Clinical Pathology.

[11]  P. Boutros,et al.  Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues , 2009, Laboratory Investigation.

[12]  F. Slack,et al.  MicroRNAs: tools for cancer diagnostics , 2009, Gut.

[13]  Jennifer Couzin,et al.  MicroRNAs Make Big Impression in Disease After Disease , 2008, Science.

[14]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[15]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[16]  F. Nielsen,et al.  MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling. , 2009, The Journal of investigative dermatology.

[17]  Kazuhiko Hayashi,et al.  Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. , 2007, RNA.

[18]  Ruian Xu,et al.  Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. , 2009, Current cancer drug targets.

[19]  C. Croce,et al.  MiRNAs and cancer. , 2009, The American journal of pathology.

[20]  Zhihai Ma,et al.  Profiling and discovery of novel miRNAs from formalin-fixed, paraffin-embedded melanoma and nodal specimens. , 2009, The Journal of molecular diagnostics : JMD.

[21]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[22]  R. Bernards,et al.  Enabling personalized cancer medicine through analysis of gene-expression patterns , 2008, Nature.

[23]  T. Brabletz,et al.  Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and MT1-MMP in colorectal carcinomas. , 2004, International journal of cancer.

[24]  F. Tang,et al.  MicroRNA expression profiling of single whole embryonic stem cells , 2006, Nucleic acids research.

[25]  A. Witteveen,et al.  Converting a breast cancer microarray signature into a high-throughput diagnostic test , 2006, BMC Genomics.

[26]  Michael Z Michael,et al.  Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.

[27]  C. Croce Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[28]  M. Monden,et al.  Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. , 1999, Nucleic acids research.

[29]  G. Lutz,et al.  Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice , 2008, BMC biotechnology.

[30]  T. Brabletz,et al.  β‐Catenin activates a coordinated expression of the proinvasive factors laminin‐5 γ2 chain and MT1‐MMP in colorectal carcinomas , 2004 .

[31]  J. Budczies,et al.  Heterogeneous expression of Wnt/β‐catenin target genes within colorectal cancer , 2007, International journal of cancer.

[32]  J. Hsu Multiple Comparisons: Theory and Methods , 1996 .